The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Radiomics
Leadership - Radiomics
Stock and Other Ownership Interests - Radiomics
External validation of a radiomic signature to predict HPV (p16) status from standard CT images of anal and vulvar cancer patients.
 
Ralph T.H. Leijenaar
Employment - Radiomics
Leadership - Radiomics
Stock and Other Ownership Interests - Radiomics
Patents, Royalties, Other Intellectual Property - IMAGE ANALYSIS METHOD SUPPORTING ILLNESS DEVELOPMENT PREDICTION FOR A NEOPLASM IN A HUMAN OR ANIMAL BODY (PCT/NL2014/050728)
 
Sean Walsh
No Relationships to Disclose
 
Akshayaa Vaidyanathan
Employment - Radiomics
Research Funding - Radiomics
 
Fadila Zerka
Employment - Radiomics
Research Funding - Radiomics
 
Mariaelena Occhipinti
Employment - Radiomics
Leadership - Radiomics
 
Denis Danthine
No Relationships to Disclose
 
Frederic Kridelka
No Relationships to Disclose
 
Roland Hustinx
No Relationships to Disclose
 
Wim Vos
Employment - Radiomics
Leadership - Radiomics
Stock and Other Ownership Interests - Radiomics
 
Julien Guiot
No Relationships to Disclose
 
Michelle Leech
No Relationships to Disclose
 
Charles Gillham
No Relationships to Disclose
 
Ciara A. Lyons
No Relationships to Disclose
 
Aileen Flavin
No Relationships to Disclose
 
Philippe Lambin
Stock and Other Ownership Interests - Radiomics
Consulting or Advisory Role - PT Theragnostic/DNAmito; Radiomics; Varian Medical Systems
Research Funding - ERC-ADG-2015, n° 694812 - Hypoximmuno; Euradiomics; ImmunoSABR; JTC2016 “CLEARLY”- n° UM 2017-8295; RAIL - n°673780
Patents, Royalties, Other Intellectual Property - N2024482; N2024889; PCT/NL2014/050248; PCT/NL2014/050728
 
Pierre Lovinfosse
No Relationships to Disclose